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Traumatic brain injury (TBI) due to explosive blast exposure is a leading combat casualty.
It is also implicated as a key contributor to war related mental health diseases. A clinically
important consequence of all types of TBI is a high risk for development of seizures and
epilepsy. Seizures have been reported in patients who have suffered blast injuries in the
Global War on Terror but the exact prevalence is unknown. The occurrence of seizures
supports the contention that explosive blast leads to both cellular and structural brain
pathology. Unfortunately, the exact mechanism by which explosions cause brain injury is
unclear, which complicates development of meaningful therapies and mitigation strate-
gies. To help improve understanding, detailed neuropathological analysis is needed. For
this, histopathological techniques are extremely valuable and indispensable. In the follow-
ing we will review the pathological results, including those from immunohistochemical and
special staining approaches, from recent preclinical explosive blast studies.
Keywords: blast, traumatic brain injury, post-traumatic epilepsy, seizures, animal models, neuropathology,
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INTRODUCTION
Blast-related traumatic brain injury (TBI) is a frequent outcome
of exposure to explosive device detonation. During the Global War
on Terror (GWOT), which includes both Operation Iraqi Freedom
(OIF) and Operation Enduring Freedom (OEF) in Afghanistan,
the use of improvised explosive devices (IED), vehicle borne IED
(VBIED), and improvised rocket assisted mortars (IRAM) resulted
in a significant number of blast-related TBI (1–4). During the over
10 years of GWOT, almost 290,000 U.S. military personnel suffered
TBI of which 68% was due to explosive blast exposure (5, 6).
The use of individual body armor systems (IBAS) reduces the
incidence of lethal thoracic and abdominal combat related injuries
dramatically when compared to previous wars when this protective
equipment was not used. Thus, many soldiers survive who would
not have had they not worn IBAS. An untoward consequence of
increased survival is that blast-related TBI became more prevalent
than in previous conflicts (2). These victims suffer a spectrum of
neurological disorders ranging from subtle mild cognitive impair-
ment, affecting the ability of a person to perform under demanding
conditions, to severe disruption of brain function as serious as
coma. These effects can be temporary or chronic. If the latter, they
can have significant negative impact on patients and their families
for decades at great emotional and economic costs to themselves
and society.
The prevalence of epilepsy among GWOT TBI patients is
unknown. From evidence derived from prior wars, it is expected
that about 10–25% of patients with closed head TBI and over 50%
of patients who have penetrating TBI will develop post-traumatic
epilepsy (PTE) (7). The Department of Defense reports that 1.5%
all combat related GWOT TBI are from penetrating injury (6).
PTE can take any form of epilepsy but temporal lobe epilepsy
(TLE) predominates with up to 62% of TBI patients suffering this
type (8). It is important for clinicians to be aware that up to 15%
of TBI patients from prior wars did not manifest seizures until
five or more years after their injury (7). Recognizing this, the Vet-
erans Administration (VA) has established a national network of
Centers of Excellence for Epilepsy, which will provide long-term
surveillance and care for these patients.
Most seizures occur within the first 2–3 years after the traumatic
event, although the risk for developing PTE remains elevated for
many years after injury. About 50% of patients, with even mild TBI
(mTBI), who suffer early seizures, i.e., within the first 7 days after
injury, will progress to PTE (9, 10). The highest risk for developing
seizures correlates with TBI severity. Increased risk is associated
with structural lesions such as dural penetration and intracra-
nial hematoma. Findings from the Vietnam head injury survey
show that cortical involvement, brain tissue loss, and intracranial
retained metal fragments are high risk factors (11, 12).
During the last few years, the present and potential long-term
impact of blast-related TBI among military personnel has fueled
an increasing number of studies aimed to better understand the
mechanisms of injury and characterize the pathobiology of blast-
related TBI in order to improve its prevention detection and
treatment. This effort is particularly relevant to combat related
mTBI, where blast accounts for 72% of cases (13).
Confusion is often associated by the use of the words “primary”
and “secondary” to define both physical causal mechanisms lead-
ing to injury and the neuropathology of the tissue response. In the
case of tissue response, “primary” refers to the immediate tissue
damage caused by the physical force such as tissue disruption from
a blow to the head or a penetrating projectile as it traverses through
brain parenchyma. Secondary injury relates to the pathophysio-
logical response to the injury such as inflammation, excitatory
amino acid release, or expression of reactive oxygen species. When
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referring to the physical explosive blast force causing TBI, primary
refers to the direct injurious mechanism of the explosive blast
wave. Secondary injury refers to TBI caused by being struck by
material (bomb casing fragments, rocks, and dust) propelled by
the blast, tertiary to the victim being physically thrown leading to
an impact injury and quaternary for all other mechanisms, such as
burns from fireball related burns, toxic fumes, radiation, etc. (14).
“Primary blast-induced injury” thus refers to the tissue damage
caused by the explosive blast wave alone. A leading hypothesis for a
primary mechanism for how explosive blast causes primary brain
injury is that shock waves transit across the target tissue caus-
ing its acceleration and deformation. The extent of tissue damage
depends on the shape of the blast shock wave, its peak overpressure
and pulse duration, and the tissues’ natural resonant frequencies
(3, 15, 16). The ideal blast shock wave can be represented by
the Friedlander curve (17). The injurious effect of this primary
blast mechanism is most significant in hollow organs including
tympanic membranes, lungs, and gastrointestinal tract (18–26).
Another hypothesized primary mechanism is that shock waves
impact the torso and are then transmitted to the brain causing TBI
(27–31). In particular, it has been proposed that, indirect transmis-
sion of kinetic energy from the blast shock wave traveling through
the large vessels of the body plays a key role in causing TBI. The
blast overpressure compresses large body cavities, which creates
oscillating waves inside the fluid contained in large abdominal
and thoracic vascular vessels. The oscillating waves are conducted
cephalad through these fluid columns into the brain resulting in
both morphological and functional damage. Experimental data
suggest that both direct (32) and indirect mechanisms (33) have
important roles in the pathogenesis of blast TBI.
In order to test these proposed hypotheses and clarify the
underlying pathophysiology in blast TBI, different preclinical
methods have been developed using either shock or explosive blast
tubes or open-field blast experiments (8, 19, 34). From these stud-
ies, extensive data has been amassed on blast shock wave–tissue
interaction, blast exposure related cognitive, and behavior changes
and brain pathology.
In this review, we focus on the pathology of blast-induced TBI
from recent animal studies, summarizing gross and microscopic
findings, tissue staining methods, and relevant neuropathology.
SEIZURES AND EPILEPSY FOLLOWING TRAUMATIC BRAIN
INJURY
Epilepsy is a common disorder for which well-established and
widely accepted animal models exist. These methods use either
chemical or electrical approaches to induce seizures. For PTE
study, injury is recreated using traditional experimental closed
head TBI methods, such as fluid percussion injury (FPI) and
controlled cortical impact (CCI), and penetrating head TBI,
such as balloon inflation penetrating ballistic brain injury
(PBBI) (35–39).
Acute TBI causes sudden changes in brain metabolism, blood
flow,and homeostasis increasing the risk of immediate and chronic
recurrent seizures (40, 41). One leading mechanistic hypothesis of
PTE is contact between intracranial blood and the neuropil lowers
seizure threshold (42). However, the conditions for closed head
PTE are likely more complex and encompass a number of active
TBI related processes. The physical forces causing head impact
can create a variety of conditions favorable for seizures, such as
acceleration, rotation, contusion and shearing of the blood vessels
and fiber tracts, leading to hemorrhages, axonal injuries, gliosis,
microglia activation, and Wallerian degeneration. Altered cerebral
vasomotor regulation leading to blood flow disturbances, intracra-
nial pressure changes, and altered vascular permeability can poten-
tially contribute to by increasing extracellular calcium, glutamate,
and reactive oxygen species formation. Iron from hemoglobin and
transferrin accumulates in the brain as hemosiderin enhances the
formation of toxic free radicals (40, 42, 43). Disrupted fiber tracts
results in anterograde transynaptic neuronal degeneration with
the loss of inhibitory interneurons thus lower seizure threshold.
Release of aspartate, glutamate, and activation of NMDA recep-
tors with reactive gliosis may also be contributing causative events
leading to PTE (44). The size of the injury and the underlying
pathophysiology can also alter the occurrence and intensity of
non-convulsive seizures (NCS).
For penetrating TBI, PBBI generates more delayed and spo-
radic seizures compared to infarction following permanent middle
cerebral artery occlusion (MCAO), a model of a stroke, with more
acute and intense NCS soon after the injury (37, 45). There is a
correlation between the volume of the infarct and the NCS activity
in the MCAO model but the volume of the lesion after PBBI does
not correlate with the seizures. However, there is a positive correla-
tion with the ballistic kinetics of the PBBI and the size of the cavity
created by different sizes of the inflated balloon (i.e., 5, 10, 12.5%
PBBI) (46). It appears that seizure activity is sensitive to both the
size of the injury and the ballistic kinetics and there is a signifi-
cant difference in the timing and intensity of NCS after MCAO
and PBBI. The results of these studies suggest that injury-specific
treatment strategies need to be considered.
Histopathological findings in experimental models of PTE
show similar changes to those of human TLE. Patients with TLE
are usually classified in either the mesial TLE group or in the
lateral or neocortex TLE group. Mesial structures of the tempo-
ral lobe with epileptogenic potential are the hippocampus and
occasionally the amygdala and the entorhinal cortex (47, 48).
Interestingly, histology analyses of hippocampal tissues from TBI
patients with blunt head trauma or acceleration injury show simi-
lar cellular and structural changes compared to the pathology from
non-trauma patients with TLE. Histology reports from patients
operated on for TBI or drug-refractory TLE show direct hip-
pocampal contusion, hippocampal sclerosis, and neuronal cell loss
in the CA1–CA4 sectors with relatively mild histological changes
in CA2 and the dentate gyrus. In a patient population with pro-
longed survival following head trauma the neural cell loss was
significant in all hippocampal pyramidal cell subfields (49). The
hippocampal degeneration appears to be progressive in nature
revealing more severe neuropathological alterations in patients
surviving more than 6 months than in patients with <1 week
survival (50–53). Reactive astrogliosis is also detectable in TLE
with increased expression of glial fibrillar acidic protein (GFAP).
Blood–brain barrier (BBB) opening can lead to astrocyte acti-
vation through albumin-mediated transforming growth factor β
(TGFβ)-dependent signaling (54–56). Other neuropathological
findings in surgical specimens from patients with TLE described
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granule cell dispersion and temporal lobe sclerosis (47). Other,
less frequently affected regions of the brain include selective
neurons of the thalamus, basal forebrain, cerebellum, and brain
stem (57, 58).
In animal models, FPI causes mossy fiber sprouting demon-
strated by Timm staining in the ipsilateral hippocampus in rats
with the loss of dentate hilar neurons (35). CCI generates com-
mon seizure risk factors in the brain, such as epidural hematoma,
subdural hematoma (59), cell loss in the cortex and hippocampus,
and neurogenesis in the dentate gyrus (60–63). CCI also results
in mossy fiber sprouting in the dentate gyrus ipsilaterally in mice
with concurrent late spontaneous post-traumatic seizures similar
to human TLE (36). Indeed, the hippocampus seems to be one
of the primary sites in epileptogenesis as there is increased acetyl-
cholinesterase staining in human temporal lobe seizure specimens,
especially in the outer portion of the molecular layer of the dentate
gyrus (64).
Interestingly, whereas various experimental blast methods and
studies exist to investigate brain injury, none have reported
seizures. This raises the issue whether blast causes neuropathology
that is distinct from blunt force. Blast waves can create simi-
lar neuropathological changes in the brain, most specifically in
the hippocampus, as those observed in experimental PTE ani-
mal models. There is also evidence of neurodegeneration, axonal
injury, and astrocytosis in the molecular layer of the hippocampus
and the dentate gyrus at various short and long-term survival times
(65–69). One confounding experimental issue is use of anesthetic
agents when performing blast experiments. This is to provide
humane treatment to subjects but may have the unintentional
effect of suppressing spontaneous seizure activity. Furthermore,
studies of reduced seizure threshold have not yet been reported. It
should be noted that explosive blast study is a relatively new area
of neuroscience research. The primary focus of these early blast
studies has been to characterize the underlying physical mecha-
nisms and pathophysiology that causes brain injury and not yet
the development of PTE. Thus, these studies are limited largely to
neuropathological and behavioral evaluations. Moreover, apply-
ing well-developed animal models for PTE, such as CCI or LFP,
creates more reproducible injury and neuropathological changes
in the brain. Injuries caused by CCI, LFP, or PBBI devices could
be more circumscribed and focused to the brain area of interest
that trigger PTE. Finding an ideal and reliable experimental blast
TBI model with equivalent well-established characteristics of brain
injury is still in progress. It is clear that more research is needed to
study the relationship between blast TBI and PTE (50).
Animal models are useful in elucidating mechanisms under-
lying and structural alterations associated with PTE. They pro-
vide a rational basis by which more effective treatments may be
developed. It is also important to be familiar with these exper-
imental methods because the results of these studies, especially
the observed histological changes in the central nervous system,
provide a deeper understanding of the underlying pathophysiolo-
gies of the various types of TBI. It must be noted again that none
of these traditional models use explosive blast. Thus, the insights
gained from these animal models may be limited as they pertain
to combat related explosive blast TBI.
EXPERIMENTAL MODELS OF BLAST-INDUCED
NEUROTRAUMA
Appropriate clinical and military-relevant experimental animal
methods are essential to characterize injuries and disorders of
blast TBI. The injury model should be reproducible with a clearly
identified injurious component simulating the features of human
blast TBI. Injury severity should be predicted by the different
mechanical properties of the injurious agent and the determined
end-points of injury should be reflected by the chosen injurious
component of the blast (28).
Various test methods are used to model explosive blast injuries
suffered by humans. The most frequently used experimental mod-
els are open-field blasts, blast tubes, and shock tubes (28). An
open-field blast is when an explosive device is detonated in an
open area. It may be suspended above or placed directly on the
ground. Subjects are located a specific standoff distance away
from the device. This is the most accurate representation of the
human condition. However, as in actual IED blasts, the shock
waves produced are complex as they are subject to reflection
off the ground and other surfaces. The fireball and debris cloud
may contribute to the injury. Thus, it is difficult to study pri-
mary blast effects alone using this approach. For that reason, tubes
are used.
In explosive blast tube experiments, a blast wave (shock wave
plus blast wind) is created by the detonation of an explosive charge.
The advantage of this approach, as compared to open-field blasts,
is that equivalent blast intensities at the target can be achieved with
significantly smaller explosive charges. Moreover, the experimental
setup allows for the exposure of experimental subjects to a “pure”
blast event without reflected shock fronts from the ground or other
surfaces. Isolation of the primary blast mechanism is facilitated
by adequate immobilization (to minimize tertiary mechanism),
using uncased explosive (to prevent secondary mechanism), and
placement of the subject beyond the detonation fireball (to avoid
quaternary mechanism). Examples of blast tubes are the tube
developed by Parks used by Bauman et al. (67) and De Lanerolle
et al. (70) to study blast-induced TBI in swine, and the Clemed-
son tube (71) used in Sweden to study the blast-induced TBI in
rat (72, 73).
The tube developed by Parks is 70-feet long, open at both ends
and has three sections: a 6-feet long heavy walled driver chamber
(where the explosive is detonated) with a diameter of 34′′, a 10-feet
expansion cone, and a 50-feet test section, with a 6-feet diameter.
The standoff distance is typically 15–25 feet.
The Clemedson tube is much smaller (about 1.5 m in inner
length), closed at the detonation end, represented by a conical
shaped chamber about 0.57 m deep. The test section (<1 m long)
is cylindrical, with an inner diameter of 0.4 m. The standoff is
about 1 m. Two consequence of the difference in size and standoff
is that the Clemedson tube can be used only for smaller animals
and that blast pulse durations will be shorter.
Obviously, a method using an explosive is the most accurate way
to study explosive blast effects. However, there are significant prac-
tical considerations when using these blast tubes. Requirements
include specialized testing locations (usually, ranges), personnel
specifically trained in the safe use of explosives, and expense
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associated with these. In addition, explosive blasts, whether in
the open-field or in a tube are typically carried out in an out-
door setting and are consequently subject to weather and other
environmental conditions (74).
Shock tubes using compressed gas, such as helium, as opposed
to explosives are an alternative to blast tubes. They are safer, more
cost effective, and can be used indoors. These tubes are smaller
than explosive-driven tubes and are closed at one end. They con-
sist of a“driver”section at the closed end, separated from a“driven”
section by a frangible or breakable diaphragm composed of mylar
or cellulose acetate. The process begins with the generation of
high pressure by the pumping of gas within the closed off driven
section. When the pressure reaches a critical level, the diaphragm
ruptures creating a shock wave. The shock wave characteristics
can be controlled or tuned by changing subject standoff from the
diaphragm, varying the membrane material or thickness, chang-
ing the shape of the closed end of the driver, and using different
gases to pressurize the membrane. Similar to blast tubes, most
shock tubes are designed to contain the subject animal within
their “driven” section. Examples are those used at Walter Reed
Army Institute of Research (33), the University of Kentucky in
Lexington (75), Wayne State University (76), and Johns Hopkins
University (77). In addition, there are smaller models of shock
tube that are designed to generate a shock wave to impact a target
outside the tube itself so as to study the effect on a specific body
region, such as the head or the chest (30, 33, 65, 66, 78–83). Exam-
ples of this latter type are those used at the Florida Institute of
Technology and Banyan Biomarkers, Inc. (66) and the University
of Toronto (83).
Shock tubes have their own important drawbacks. Very impor-
tantly, the physics of the gas-driven shock waves may differ from
explosive shock waves. If so, the injury pattern produced may not
be comparable to the human condition. Gas-driven shock waves
are often atypical, showing an apparent pressure plateau follow-
ing the initial pressure peak. This is likely due by the existence of
two successive pressure waves; the first directly coming from the
bursting diaphragm and the second reflected back from the tube
end. A single and more typical-looking pressure wave is obtained
by allowing sufficient standoff, which permits the reflected wave
to reach and fuse with the direct one. Another issue is the possi-
ble impact of diaphragm fragments on the subject. Even low mass
fragments, when accelerating at high rates, will exert significant
force on subjects, which means the resultant injury is not pri-
mary blast effect alone. Finally, the physical load of multiple small
fragments may affect the dynamics of body–head acceleration.
A common issue of both explosive-driven and gas-driven shock
tubes is the jet stream effects created near the tube exit. This jet
stream creates an unrealistic dynamic pressure effect that can be
avoided by placing the target sufficiently far from the tube’s exit or,
in the case of external exposure, sufficiently off axis to the tube’s
nozzle (66, 83).
Both explosive and gas-driven shock tubes aim to recreate pri-
mary blast conditions with ideal Friedlander waves. Real world
exposures are more complicated as reflected shock waves create
a complex interaction with primary shock waves. To replicate
war related conditions, some investigators have carried out studies
using surrogates of military vehicles, buildings, or bunkers (67, 68,
74, 84, 85). Each is appropriate for recreating real world condition
but methodological differences interfere with generalization of
results (74).
Finally, rodents, pigs, rabbits, and non-human primates
(NHPs) used for blast studies widely differ in their neuroanatomy
and neurophysiology, which can further contribute to the varia-
tions in the observed pathological and physiological changes of
experimental blast injuries (28, 74).
PATHOLOGY OF BLAST-RELATED BRAIN INJURY
Recent studies have identified candidate pathophysiological
processes that likely play key roles in the genesis of blast TBI. From
detailed histopathological analyses, common findings include
small and larger intracranial hemorrhages, edema, vasospasm,
neuronal damage/degeneration, focal or diffuse axonal injury, glial
cell activation, and inflammatory reactions (1, 86). Optimizing
identification of tissue injuries is highly dependent on using the
most appropriate histological methods and stains as well as on tim-
ing after injury ictus and sampled brain region. For general mor-
phological examinations (neuronal injury, cell death, intracranial
hemorrhages, edema formation, and inflammation) hematoxylin
and eosin (H&E) and cresyl-violet are used. Luxol-fast blue, a spe-
cial myelin stain, is used routinely for myelin damage. For the
detection of more subtle cellular changes, immunohistochemistry
(IHC) is the general method. One of the most widely examined fea-
tures of TBI is diffuse axonal injury. Traditionally, axonal injury is
detected by silver staining or β-amyloid precursor protein (β-APP)
IHC (87–90). GFAP and various microglia stains are used to label
activated astrocytes and microglia cells (91–93). For ultrastruc-
tural examinations at the subcellular level electron microscopy is
the preferred method.
As part of the research program PREVENT (Preventing Violent
Explosive Neurotrauma), Baumann et al. use a swine model and
the Parks explosive-driven shock tube to study explosive blast TBI
(67). Within the tube the pigs are restrained in a sling that mini-
mizes movement during the blast, and exposes subjects side-on
to the blast. In addition, these investigators use both a surro-
gate military vehicle and 2-room building so as to recreate more
typical complex shock waves. Brain specimens are obtained at
2 weeks after blast exposure. For axonal injury, a modified Gallyas
silver method, as made available by FD Neurotechnologies, is
used (94). This staining technique labels injured/degenerating
axons and neurons as early as 24 h after injury. IHC is used
to label cells positive for GFAP as well as other markers. Silver
staining reveals degenerated axons in the ipsilateral white mat-
ter tracts of corona radiata and cerebellum. Astrocyte activation
is evident in the ipsilateral white matter of the cortex and in
multiple layers of the ipsilateral hippocampus. Elevated GFAP,
neuron specific enolase (NSE), and myelin basic protein (MBP)
expression are also detected 6, 24, and 72 h after exposure. Addi-
tional observations include changes in the electroencephalogram
(EEG) patterns, vasospasm in carotid artery branches, and distur-
bances in the movement of the pigs involving major joints and
limbs (knees and metacarpals). Detailed neurological function
assessment is made using motion analysis technologies for gait,
EEG telemetry, spatial memory testing, and cerebral angiography.
However, anatomical differences between swine and human skulls
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can generate discrepancies in the interpretation of biological and
biomechanical events.
A similar approach to blast exposure is used in a swine study
carried out by de Lanerolle et al. (70). Specimens are collected
72 h and 2 weeks after blast. Paraffin-embedded sections are used
for standard and immunohistochemical stainings: H&E, Luxol-
fast blue, Fluoro-Jade B (neurodegeneration), GFAP, β-APP, and
CD68 (macrophage/microglia marker).
Analysis reveals very limited neuronal injury with Fluoro-Jade
B failing to reveal positive cells. Intracranial hemorrhages and
fiber tract demyelination are not present. Dark, shrunken neu-
rons are noticed but since they are also seen in controls, their
presence is attributed to mechanical manipulation of the tissue.
Red (eosinophil) neuronal degeneration is occasionally visible
throughout the neural tissues both in blast and sham control
animals. β-APP IHC is positive in the periventricular white mat-
ter close to the lateral ventricle in all groups. The axonal injury,
around or close to the ventricles, is explained by a fluid-tissue
interface effect generated by local pressure transients at the site,
or ventricular volume increase strong enough to cause axonal
deformation. GFAP activity is also enhanced in the different layers
of the hippocampus and cortical gray and white matters. Their
morphology is different from those activated by neuronal injury
and the number of activated astrocytes in the hippocampus is
significantly higher in the animals exposed in the vehicle or the
building. Microglia activation is visible in the central white matter
and corpus callosum. One explanation of the glial activation is the
transient opening of the BBB triggering the activation of astrocytes
by extravasated albumin resulting in excitatory neuronal injury.
These findings together support the notion that astrocytosis and
periventricular axonal injury may have an important role in the
potential for long-term TBI exacerbations, mood, and cognitive
disorders.
Lu et al. report their NHP study using open-field blast with
either single or double-blast exposure (68). The outcome of expo-
sure to the following conditions is evaluated and compared: single-
blast at 80 kPa (equivalent to 11 psi; SBL), single-blast at high
intensity at 200 kPa (equivalent to 29 psi; SBH), and double-blast
(DBL) at 80 kPa. In the DBL group, exposures are carried out
3 days apart. Specimens are obtained at either 3 days or 1 month
post-blast. General morphological analysis uses H&E and TUNEL
for apoptosis. IHC is used for the detection of S100B and GFAP
(for astrocyte reaction), MBP, neuronal nuclear antigen (NeuN),
β-APP, aquaporin-4 (AQP4, for water channel identification),
and oligosaccharide-specific agglutinin I anti-lecithin antibody (to
reveal microglia cells). Electron microscopy is also performed in
order to detect ultrastructural changes.
At gross pathological examination, no visible damage can be
detected in the brain, and only minor injuries are noticeable in the
lungs. MRI only detects a right anterior lobe cerebellar lesion in a
single subject. Microscopically, there are neuronal cell changes in
the cortex, the cerebellar Purkinje-cells and the hippocampus such
as dark, shrunken neurons with distorted dendrites in all groups
with elevated NeuN reaction. Apoptotic cells are rarely co-labeled
with GFAP and MBP in the subcortical areas 1 month after injury.
The number of apoptotic cells is increased and MBP reaction is
reduced in the SBH and DBL groups. Increased β-APP reaction
is also observed in the neuronal perykarion and around axons.
Besides the neuronal alterations in the cerebellum, the astrocytes
show reactive changes in the SBH and DBL groups by S100,
GFAP, and AQP4 staining. Electron microscopy on tissues from
the cerebellum reveal structural damages in the nucleus, mito-
chondria, and cytoplasmic filaments of the Purkinje-cells, with
the formation of stacks of smooth endoplasmic reticulum, myelin
sheath degeneration, astrocyte filamentous and end-feet hypertro-
phy, microglial activation, and severe oligodendrocyte cell injury.
Interestingly, vascular changes are observed in the cerebellum,
with obliterated and collapsed capillaries, endothelial cytoplasm
vacuolations and accumulation of perithelial cells.
These pathological results correlate with observed behavioral
changes in motor coordination and working memory. The lesion
detected by MRI shows widespread pathology in the above
described area suggesting the vulnerability of the cerebellum.
The accumulation of the smooth endoplasmic reticulum in the
Purkinje-cells can be a part of a protective mechanism by cal-
cium sequestration. Furthermore, damage to the oligodendro-
cytes, astrocytes, and capillaries likely contribute to cognitive,
motor and other neurological dysfunctions, brain edema, and
ischemic-hypoxic damage. Although the study provides a broad
pathological overview in blast TBI, the sample size is relatively
small and further long-term behavioral studies are required to
define neurological deficits.
To determine whether or not torso IBAS mitigates of TBI, Long
et al. use a compressed air-driven shock tube to create blast injury
in chest-protected and unprotected rats (33). Chest protection is
a Kevlar vest that completely covers the rat’s thorax but leaves the
head exposed. The animals are placed in a transverse prone posi-
tion in a wire-mesh holder across the mouth of the shock tube.
Brain samples are collected 2 weeks after blast exposure. Brains
are cresyl-violet, thionine, and silver-stained. The observed patho-
logical alterations are torso protection and intensity dependent.
Neural cell loss is observed, along with gliosis, fiber degeneration,
hemorrhage, and necrosis, in the brain of unprotected rats exposed
to 147 kPa (equivalent to 21 psi), but not 126 kPa (equivalent to
18 psi) blasts. These changes are more severe in the hemisphere
facing the blast. Brains from rats exposed to the lower blast show
extensive silver-stained fiber degeneration that is bilateral.
Chest protection does not affect the pathological outcome in
147 kPa blast – exposed rats but largely prevents fiber degenera-
tion in the brains of animals exposed to 126 kPa blasts. No evident
pathology is observed in the brains at the lowest blast intensity
level (114 kPa or 16 psi). These findings suggest that chest pro-
tection does contribute to TBI mitigation, particularly at lower
blast intensities. Furthermore, these observations lend further sup-
port to that of prior studies (31) that the second hypothesized
mechanism of how blast injures brain may be valid.
Studying head and torso protection, Koliatsos et al. use a shock
tube generating overpressure with compressed helium, with mice
placed inside the shock wave tube fixed in a wire-mesh holder
disallowing body or head motion (95). The torso and/or head
of each mouse are protected by a Plexiglas cover. Animals are
exposed to different blast intensities either in a prone or supine
position. Social recognition, spatial memory, and motor coordi-
nation outcome measures are used. Brains are collected at 1, 3, 5,
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7, and 14 days after exposure. Internal organs – lungs, liver, heart,
spleen, and kidney – and eyes were also examined. Standard for-
malin immersion-fixed paraffin-embedded, and perfusion fixed
frozen tissues are stained with routine H&E, various special and
immunostains (cresyl-violet, Mallory trichrome, elastic fiber stain,
Fluoro-Jade, APP, phosphorylated neurofilament, and TUNEL).
FD Neurosilver kit is used to detect axonal injury.
Findings are injuries to the internal organs (lung, heart, liver,
kidney, and spleen) that are mainly hemorrhages and hemor-
rhagic infarcts. These correlate with blast wave intensities and body
position. Neuropathological results of blast at lower blast inten-
sity include extensive silver-stained axonal injury involving the
cerebellum, brainstem, corticospinal tracts, optical, and auditory
pathways. Axonal injury is more prominent 14 days after the expo-
sure. No histological reactions are detected in animals at 1, 3, and
5 days after blast. Special stains fail to reveal any brain hemorrhage,
neuronal injury, or cell death. Occasional APP and phosphorylated
neurofilament positivity is visible in the corpus callosum and ante-
rior vermis. Interestingly, when torso protection is applied, there is
no observable white matter tract degeneration and no behavioral
deficits.
The finding that torso protection is neuroprotective in blast,
especially against diffuse axonal injury, has both important clini-
cal and mechanistic implications. These findings, consistent with
those reported by Long et al. (33), point to the likely role of the
second mechanism of blast TBI, which is blast chest compression
and vascular cephalad conduction of shock waves into the brain.
Clinically, this supports the military’s use of IBAS as likely help-
ing to protect service members from both blast-related torso and
brain injuries.
The importance and usefulness of silver staining is further
emphasized and convincing in work by Garman et al. (65). As
part of the PREVENT blast program, they conduct an initial neu-
ropathological characterization in body protected rats exposed
to blast. Animals are positioned in a helium-driven shock tube
within a wedge-shaped holder protecting the torso but leaving the
head exposed. Besides protecting the torso, the holder increases
the intensity of the shock wave at the target, by creating a mach
stem along the side of the wedge. To prevent gross motion, the
head is held in place with a leather sling. The shock tube gener-
ates a peak pressure of 35 psi, resulting in 25% mortality from
apnea. Brains are collected at 1 and 3 days and then 2 weeks.
H&E, de Olmos amino cupric silver, and immunostains for GFAP,
ionized calcium-binding adapter molecule 1 (Iba1) and CD68
(for microglia activation), APP, and IgG (for brain edema) are
performed. Not surprisingly, silver staining is the most sensi-
tive method in identifying TBI, labeling axonal damage as well
as neuronal degeneration.
Neuronal degenerations including axons and dendrites are the
most prominent histological alterations during the first 2 weeks in
blast-exposed rats with body protection. Degenerating neuronal
cell bodies are most detectable at 1 and 3 days showing a scattered
distribution with some preference in various cortical regions, CA1
pyramidal layer of the hippocampus and the cerebellar cortex, the
latter suggesting synaptic or terminal degeneration. The axonal
damage marked by silver staining is prominent at all-time points,
but most evident after 2 weeks, affecting both sides of the brain
except for the entorhinal cortex and hippocampal dentate gyrus,
which show stronger contralateral reaction. This is believed to be
caused by a diffraction effect or localized shock amplification on
the contralateral side of the skull or by the effect of diffraction
coupled with skull flexure. The injured fiber tracts include various
long tracts such as the optic tract, internal and external capsules,
thalamic pathways, cerebral and cerebellar peduncules, trigemi-
nal tracts, and pyramids. APP-based detection of axonal injury is
minimal. There is no astroglial reaction and only weak microglia
activation is visible adjacent to brain regions with neuronal degen-
eration. Breach of the BBB using IgG is only seen in the 1 day group
mostly on the contralateral side of different brain regions.
This study demonstrate that, in this blast model, silver staining
was more effective in revealing axonal injury than APP, a marker
which is most prominently detected in axonal injuries related to
acceleration/deceleration mechanisms (96, 97). This study also
provides evidence of blast-related breach of the BBB. However,
its relation with axonal injury, if any, is unclear.
A study by Goldstein et al. (69) examines the connection
between blast-induced TBI and chronic traumatic encephalopathy
(CTE). Neuropathological examinations of four military veter-
ans who died in blast or concussive injuries show similar brain
changes as four athletes who suffered concussive injuries in foot-
ball, wrestling, etc. The image is correspondent with CTE, a tau
protein-related neurodegenerative disease (98–101). These human
neuropathological observations are compared with the pathologi-
cal outcome of mice exposed to blast. In this model,mice are placed
prone within a shock tube. Only the heads are exposed, side-on, to
the gas-driven shock wave as the rest of the body is protected within
the holding fixture. Heads are not secured for some subjects, which
allow testing of the hypothesis that blast-induced head accelera-
tion contributes to TBI. The blast is reported to be comparable
to detonation of 5.8 kg trinitrotoluene (TNT). Measurements of
intracranial pressure at the time of shock wave impact confirm
the intracranial transmission of stress waves occurs without sig-
nificant contribution of torso-transmitted shock waves. Brains
are collected at 2 weeks post-blast, saline perfused, prefixed in
10% neutral-buffered formalin, block-sectioned, and post-fixed
in 4% paraformaldehyde. Serial sections are cut from paraffin-
embedded blocks and stained with various stains including IHC
for axonal injury, tau pathology, astrocytosis, and cholinergic
motor neurons. Brain tissues are also processed for ultrastructural
examinations.
Gross examinations of the brains do not show any visible
macroscopic tissue injury. By histological examinations single-
blast exposure produces CTE-like changes in the mouse brain
such as tau protein immunoreactivity, phosphorylated tau pro-
teinopathy, cortical and hippocampal neurodegeneration, perma-
nent perivascular pathology, myelinated axonopathy, and chronic
neuroinflammation with astrocytosis and microgliosis. Blast pro-
duces “dark neurons” in close proximity to abnormal capillaries
(102, 103). Moreover, axonal conduction velocity is reduced in the
hippocampus and synaptic transmission disturbances resulting
in learning and memory deficits. Head immobilization prevents
blast-induced hippocampus-related behavioral deficits. Electron
microscopy verifies persistent microvascular pathology and astro-
cyte end-feet swelling suggesting BBB compromise, which in
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turn possibly plays a role in local hypoxic, inflammatory, and
neurodegenerative changes.
The similarities between human CTE cases and the experi-
mental method described above suggest that different scenarios
can induce a common pathway leading to similar morphologi-
cal changes. The results from this mouse blast study are consistent
with the morphological, neurophysiological, and cognitive deficits
that are reported in military veterans and athletes with blast and/or
concussive-related CTE. In addition, this study is also signifi-
cant because it suggests that head acceleration plays a critical role
in TBI.
SUMMARY AND DISCUSSION
In this review, we provide a brief review on experimental mod-
els of brain trauma, development of PTE and the pathologi-
cal/histological features of TBI, including blast. Our intent is to
give the reader an overview of the most routinely used and repro-
ducible histopathological methods and neuropathological results
published on blast TBI and PTE as these represent the cellular
basis of this injury and its clinical consequence, such as seizures. It
is at this level that rational comparisons may be made among the
different TBI types as well as, very importantly, between preclin-
ical models and the human condition. Increasing demand in the
field of blast TBI to understand the physics and pathophysiology of
blast-related brain injury has produced a large number of scientific
publications reporting, sometimes contradictory, results obtained
from animal studies (28, 86). These reports provide information
about both morphological alterations in the CNS and also neu-
rophysiological and behavioral aspects of blast injury. While it is
extremely important to examine blast TBI and its consequences
in every respect, pathological evaluation is probably the ultimate
way to prove or disapprove mechanistic theories.
The pathological methods and results reviewed above underpin
several technical issues, which need to be taken into consideration
when working with tissue specimens, especially brain. The most
important is to be able to recognize tissue and cellular changes and
responses to a noxious event. It is one of the most crucial rules to
learn to recognize common artifacts in CNS tissues, which are of
no pathological significance (104). Failure to do so will lead to
conclusions that are misleading and erroneous (105–108). Arti-
facts can be caused by improper tissue handling that, many times,
are unavoidable (109) but following current guidelines could help
to overcome these potential technical issues. Nevertheless, some of
them are worth mentioning (110, 111). Microscopically, underper-
fused brain tissues demonstrate collapsed microvessels containing
blood, with tissue retraction around them and dark, basophilic
neurons are readily observable. These artifacts make histological
interpretations difficult. Not all parts of the brain will necessarily
be evenly well-perfused, but a good perfusion should produce dis-
tended vessels throughout the brain with no or minimal artifacts
(110, 111).
One of the most frequently noted and long-debated artifacts
in surgical human specimens and various experimental stud-
ies is the “dark neuron,” which is often interpreted as neuronal
degeneration or death (112, 113). Neurons are highly susceptible
to ischemic/hypoxic injuries that can be detected microscopi-
cally after 6–12 h in humans and 30–90 min in experimental
animals (104, 114). The cytological hallmark of neuronal injury is
the eosinophilic degeneration or “pink neurons.” These cells are
shrunken with eosinophilic cytoplasm, glassy, basophilic pyknotic
nucleus, and absent Nissl substance. After dead neurons and cell
debris have been phagocytosed, glial cells appear and proliferate
creating a glial scar tissue. Axonal transection, most frequently in
lower motor neurons, can produce central chromatolysis when the
cell itself is intact, the cell body is rounded and the nucleus and
Nissl substance is displaced peripherally (104, 114, 115). Apop-
totic, fragmented cells are easily recognizable even for the inexpe-
rienced eyes. “Dark neurons” on the other hand, have a shrunken
angular cell body with deeply stained cytoplasm, small, irregular,
dark basophilic nucleus with loss of details. Dendrites often have
a characteristic cork-screw shaped appearance. Such neurons are
more frequent in immersion-fixed brains but adequately perfused
material can still contain numerous dark neurons in experimen-
tal neuropathology (110, 111, 116, 117). Mechanical post-mortem
manipulation of the brain can increase the number of these neu-
rons (110, 118). Interestingly, the presence of these contracted
neurons has been reported in some acute neuropathological states
making the distinction between true neuronal degeneration and
artificial dark neurons challenging (119–122). Although neuronal
degeneration and cell death can be often detected on routine H&E
stained slides, using special stains specific for neurodegeneration
can significantly assist to recognize neuronal damage. Fluoro-Jade
B and Fluoro-Jade C are both recommended in the identification
of neuronal degeneration and the degeneration of fine neuronal
processes (111, 123). Silver staining has an important role in exper-
imental neuropathology to detect axonal injury. Even if β-APP
fails to label injured axons, silver techniques can help to detect
early, and more often, late axonal degeneration (65, 95). Master-
ing any of the silver staining technique can be challenging but
commercially available silver stain kits are easy to use and reli-
able. In general, for most neuropathological experimental studies,
a set of special and immunohistochemical basic stains can pro-
vide an initial step toward a close evaluation of the tissue samples.
The usage of negative and, ideally, positive tissue controls is of
the utmost importance. Finally, it can’t be overemphasized that
experiments, TBI or others, involving morphological evaluations
should be reviewed by experienced morphologists or pathologists
to avoid further inconsistencies among researchers (111, 124).
Fortunately, most researchers working with neural tissues are
using appropriate current pathological methods but future inves-
tigators in the field, especially those without a background in
pathology, should take into consideration the above discussed
technical details. Moreover, the validity of some of the methods
used to reproduce blast phenomenon may be lacking. The hetero-
geneity of results may be partly the result of this inadequacy and
partly reflect differences in experimental designs. When consid-
ered in balance, the collective work still reveals important insights
on mechanism of blast-related injury.
Some key findings are that explosive blast, when of suffi-
cient severity, leads to brain pathology. The most consistent
neuropathological findings are multifocal axonal and neuronal
injuries detected by silver staining, astroglial alterations, inflam-
mation with elevated cytokine and reactive oxygen species activity,
BBB anomalies, and intracranial hemorrhages. This pathology
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correlates with behavior changes such as spatial and cognitive
performance and coordination. Very important clinically is the
evidence supporting the benefits of body armor in mitigating
blast TBI as well as torso protection. This also provides sup-
porting evidence to the notion that caudal transmission of shock
waves through the thoracic and intracranial blood vessels plays
a role in TBI genesis. Also very important is the demonstration
that torso protection also mitigates diffuse axonal injury. The role
of primary blast in causing TBI is still unclear. However, it does
appear that head acceleration is an important contributor to TBI
as well.
Seizures are an important clinical consequence of all TBI.
Although the precise impact of this clinical condition on explo-
sive blast TBI recovery is still being elucidated, the finding that
explosive blast leads to consistent neuropathological brain changes
raises significant concern that seizures and epilepsy may be more
prevalent than previously suspected. Fortunately, the VA is taking
a comprehensive prospective longitudinal approach to study PTE
in blast TBI victims.
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